Laser Acupuncture versus Liraglutide in Treatment of Obesity: A Multi-Institutional Retrospective Cohort Study

Wen-Lin Yu,Yu-Ning Liao,Tsung-Hsien Yang,Ching-Wei Yang,Ting-I Kao,Pai-Wei Lee,Chiu-Yi Hsu,Jhen-Ling Huang,Yu-Tung Huang,Hsing-Yu Chen

DOI: https://doi.org/10.3390/healthcare12131279

2024-06-27

Health Care

Abstract:Background: Obesity is a global concern, driving the search for alternative treatments beyond lifestyle changes and medications. Laser acupuncture (LA) shows promise in obesity management, yet few studies compare it with FDA-approved medications. This study aimed to assess and compare LA's impact with liraglutide on weight reduction in obese individuals. Methods: Data from the Chang Gung Research Database (CGRD) (2013–2018) were analyzed. Primary outcomes included changes in body weight and BMI within 180 days, with secondary outcomes measuring the proportion achieving 5%, 10%, and 15% weight loss. Adverse events were also assessed. Results: Of 745 subjects (173 LA users, 572 liraglutide users), LA users lost more weight by day 180 (5.82 ± 4.39 vs. 2.38 ± 5.75 kg; p < 0.001) and had a greater BMI reduction (−2.27 ± 1.73 vs. −0.93 ± 2.25 kg/m2; p < 0.001). More LA users achieved 5% and 10% weight loss compared to liraglutide users (64.2% vs. 22.7%, 26.6% vs. 4.2%; all p < 0.001). After balancing baseline differences, LA's benefits remained significant. No adverse events were reported with LA. Conclusions: LA may offer superior weight reduction compared to liraglutide. Future studies should explore LA alone or in combination with liraglutide for obesity management.

health care sciences & services,health policy & services

What problem does this paper attempt to address?

The paper aims to address a significant issue in the field of obesity treatment, namely comparing the effects of laser acupuncture (LA) with liraglutide (an FDA-approved weight loss medication) in treating obesity. The research background indicates that with the prevalence of high-calorie diets and sedentary lifestyles, obesity has become a global health issue and is associated with an increased risk of various diseases such as cardiovascular diseases and type 2 diabetes. In light of this, researchers seek to explore alternative therapies beyond lifestyle adjustments and existing medications.

The main objective of the paper is to evaluate and compare the effectiveness of laser acupuncture and liraglutide in reducing the weight of obese individuals. The study employed a retrospective cohort design, with data sourced from the Chang Gung Memorial Hospital research database (2013-2018). The primary outcome measures included changes in weight and body mass index (BMI) over 180 days; secondary outcome measures included the proportion of individuals achieving 5%, 10%, and 15% weight loss, as well as the occurrence of adverse events.

The study results showed that the laser acupuncture group had an average weight loss of 5.82 kg and a BMI reduction of 2.27 kg/m² after 180 days, significantly higher than the liraglutide group's 2.38 kg and 0.93 kg/m². Additionally, more participants in the laser acupuncture group achieved 5% and 10% weight loss (64.2% and 26.6%, respectively, compared to 22.7% and 4.2% in the liraglutide group). Notably, no adverse events were reported in the laser acupuncture group, suggesting that laser acupuncture may be a safer and more effective weight loss method.

In conclusion, by comparing the effects of laser acupuncture and liraglutide, this study aims to explore the efficacy and safety of laser acupuncture as a potential alternative therapy for obesity management. These findings provide a basis for further research on the use of laser acupuncture alone or in combination with liraglutide.